Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
Clinical trial NCT00010309 · UNKNOWN
Trial details
- NCT number
- NCT00010309
- Sponsor
- Genzyme, a Sanofi Company
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.